IntroductionLower urinary tract symptoms (LUTS) indicate the pathologies of storage, voiding, and the postmicturition phases of urination (1). The results of a large prevalence study showed that storage symptoms such as urine frequency, nocturia, urgency, and urge incontinence were more prevalent (51.3%) than other LUTS in men (2). In recent years, the paradigm shifted from the prostate to the bladder for understanding, diagnosis, and treatment strategies of LUTS in men. Accordingly, detrusor overactivity (DO) and bladder outlet obstruction (BOO) play integral roles in men with LUTS (3). Overactive bladder (OAB) symptoms have more deteriorating effects on health-related quality of life (QoL) than other LUTS (4,5). Furthermore, recent studies have emphasized that combination therapy (ComRx) with α-blockers and antimuscarinics had better results in men with BOO who had mixed symptoms (6). In contrast, LUTS in men are often still treated with therapies targeting the prostate even if they have OAB symptoms (1).